Patent application number | Description | Published |
20140139746 | SYSTEM AND METHOD FOR MULTIPLEXING VIDEO CONTENTS FROM MULTIPLE BROADCASTING CHANNELS INTO SINGLE BROADCASTING CHANNEL - A method and system for multiplexing of multiple channels of video data through a single analog broadcasting channel is disclosed. The method enables a spatial and temporal multiplexing of videos of each of the multiple channels. The multiplexed content is created as a result of multiplexing that is encoded to generate digital transport stream that is transmitted through analog medium. The system enables a STB receiver to decode each of the videos from the stream. At least one video from the multiple videos is played on the television based on user selection. | 05-22-2014 |
20140193793 | METHOD AND SYSTEM FOR DISTANCE EDUCATION BASED ON ASYNCHRONOUS INTERACTION - The invention facilitates asynchronous interaction between a geographically separated facilitator and at least one user. The said invention provides asynchronous interaction between rural classrooms (teacher-student community) and expert teachers to increase the outreach of the expert teachers much beyond that is permitted with the teachings of the prior art. | 07-10-2014 |
20150019513 | TIME-SERIES ANALYSIS BASED ON WORLD EVENT DERIVED FROM UNSTRUCTURED CONTENT - The present subject matter relates to analysis of time-series data based on world events derived from unstructured content. According to one embodiment, a method comprises obtaining event information corresponding to at least one world event from unstructured content obtained from a plurality of data sources. The event information includes at least time of occurrence of the world event, time of termination of the world event, and at least one entity associated with the world event. Further, the method comprises retrieving time-series data pertaining to the entity associated with the world event from a time-series data repository. Based on the event information and the time-series data, the world event is aligned and correlated with at least one time-series event to identify at least one pattern indicative of cause-effect relationship amongst the world event and the time-series event. | 01-15-2015 |
20150254329 | ENTITY RESOLUTION FROM DOCUMENTS - The present subject matter relates to entity resolution, and in particular, relates to providing an entity resolution from documents. The method comprises obtaining a plurality of documents corresponding to a plurality of entities, from at least one data source. Upon receiving the plurality of documents, the plurality of documents is blocked into at least one bucket based on textual similarity. Further, a graph including a plurality of record vertices and at least one bucket vertex is created. The plurality of record vertices and the at least one bucket vertex are indicative of the plurality of documents and the at least one bucket, respectively. Subsequently, a notification is provided to a user for selecting one of a Bucket-Centric Parallelization (BCP) technique and a Record-Centric Parallelization (RCP) technique for resolving entities from the plurality of documents. Based on the selection, a resolved entity-document for each entity is created. | 09-10-2015 |
20150269242 | EMAIL ANALYTICS - A method for performing email analytics is described. The method includes extracting emails from the configured email repository. The emails are then grouped into mail groups based on identification of content similarity of the emails. A network graph is then constructed for each of the mail group to identify an association of emails in the mail group based on header-level analysis of emails. Thereafter, email analytics is performed on the mail groups by clustering the mail groups into mail clusters based on temporal progression of emails in the mail groups. Key phrases are then determined based on a content analysis of emails in the mail groups in the mail clusters. The key phrases are then associated with the network graphs of the mail groups. | 09-24-2015 |
20150356752 | SYSTEM AND METHOD FOR INTERACTIVELY VISUALIZING RULES AND EXCEPTIONS - The present disclosure discloses system and method for providing perceptually efficient visualization of rules and exceptions mined from dataset. Further, parsing is performed on data-attributes associated with the rules. The data-attributes may include antecedents, consequents, ranges of the antecedents, syntax and statistics of the rules and exceptions. The visualization scheme of present disclosure present an overview first, allows semantic zooming, and then shows details on demand. Further, data attributes of the rules are mapped with visual attributes of graphical elements such as shape, color, opacity to create the perceptually efficient visualization of the rules and exceptions. Initially, the visualization shows main rule highlighting the exceptions associated and properties of the exceptions. Further, a semantic zoom slider is provided for allowing a user to navigate through different exception levels of the exception. Further, an interface is provided for obtaining additional information associated with the rules and the exceptions. | 12-10-2015 |
20160004987 | SYSTEM AND METHOD FOR PRESCRIPTIVE ANALYTICS - The present subject matter discloses system and method for executing prescriptive analytics. Simulation is performed from an input data (x | 01-07-2016 |
Patent application number | Description | Published |
20090123433 | Compositions Comprising Human Embryonic Stem Cells and their Derivatives, Methods of Use, and Methods of Preparation - The present invention relates to a pharmaceutical composition comprising of preparations of human embryonic stem (hES) cells and their derivatives and methods for their transplantation into the human body, wherein transplantation results in the clinical reversal of symptoms, cure, stabilization or arrest of degeneration of a wide variety of presently incurable and terminal medical conditions, diseases and disorders. The invention further relates to novel processes of preparing novel stem cell lines which are free of animal products, feeder cells, growth factors, leukaemia inhibitory factor, supplementary mineral combinations, amino acid supplements, vitamin supplements, fibroblast growth factor, membrane associated steel factor, soluble steel factor and conditioned media. This invention further relates to the isolation, culture, maintenance, expansion, differentiation, storage, and preservation of such stem cells. | 05-14-2009 |
20130122486 | Compositions Comprising Human Embryonic Stem Cells and Their Derivatives, Methods of Use, and Methods of Preparation - The present invention relates to a pharmaceutical composition comprising of preparations of human embryonic stem (hES) cells and their derivatives and methods for their transplantation into the human body, wherein transplantation results in the clinical reversal of symptoms, cure, stabilization or arrest of degeneration of a wide variety of presently incurable and terminal medical conditions, diseases and disorders. The invention further relates to novel processes of preparing novel stem cell lines which are free of animal products, feeder cells, growth factors, leukaemia inhibitory factor, supplementary mineral combinations, amino acid supplements, vitamin supplements, fibroblast growth factor, membrane associated steel factor, soluble steel factor and conditioned media. This invention further relates to the isolation, culture, maintenance, expansion, differentiation, storage, and preservation of such stem cells. | 05-16-2013 |
20140050706 | Compositions Comprising Human Embryonic Stem Cells and Their Derivatives, Methods of Use, and Methods of Preparation - The present invention relates to a pharmaceutical composition comprising of preparations of human embryonic stem (hES) cells and their derivatives and methods for their transplantation into the human body, wherein transplantation results in the clinical reversal of symptoms, cure, stabilization or arrest of degeneration of a wide variety of presently incurable and terminal medical conditions, diseases and disorders. The invention further relates to novel processes of preparing novel stem cell lines which are free of animal products, feeder cells, growth factors, leukaemia inhibitory factor, supplementary mineral combinations, amino acid supplements, vitamin supplements, fibroblast growth factor, membrane associated steel factor, soluble steel factor and conditioned media. This invention further relates to the isolation, culture, maintenance, expansion, differentiation, storage, and preservation of such stem cells. | 02-20-2014 |
20140051110 | Compositions Comprising Human Embryonic Stem Cells and Their Derivatives, Methods of Use, and Methods of Preparation - The present invention relates to a pharmaceutical composition comprising of preparations of human embryonic stem (hES) cells and their derivatives and methods for their transplantation into the human body, wherein transplantation results in the clinical reversal of symptoms, cure, stabilization or arrest of degeneration of a wide variety of presently incurable and terminal medical conditions, diseases and disorders. The invention further relates to novel processes of preparing novel stem cell lines which are free of animal products, feeder cells, growth factors, leukaemia inhibitory factor, supplementary mineral combinations, amino acid supplements, vitamin supplements, fibroblast growth factor, membrane associated steel factor, soluble steel factor and conditioned media. This invention further relates to the isolation, culture, maintenance, expansion, differentiation, storage, and preservation of such stem cells. | 02-20-2014 |
20140051164 | Compositions Comprising Human Embryonic Stem Cells and Their Derivatives, Methods of Use, and Methods of Preparation - The present invention relates to a pharmaceutical composition comprising of preparations of human embryonic stem (hES) cells and their derivatives and methods for their transplantation into the human body, wherein transplantation results in the clinical reversal of symptoms, cure, stabilization or arrest of degeneration of a wide variety of presently incurable and terminal medical conditions, diseases and disorders. The invention further relates to novel processes of preparing novel stem cell lines which are free of animal products, feeder cells, growth factors, leukaemia inhibitory factor, supplementary mineral combinations, amino acid supplements, vitamin supplements, fibroblast growth factor, membrane associated steel factor, soluble steel factor and conditioned media. This invention further relates to the isolation, culture, maintenance, expansion, differentiation, storage, and preservation of such stem cells. | 02-20-2014 |
20140057250 | Compositions Comprising Human Embryonic Stem Cells and Their Derivatives, Methods of Use, and Methods of Preparation - The present invention relates to a pharmaceutical composition comprising of preparations of human embryonic stem (hES) cells and their derivatives and methods for their transplantation into the human body, wherein transplantation results in the clinical reversal of symptoms, cure, stabilization or arrest of degeneration of a wide variety of presently incurable and terminal medical conditions, diseases and disorders. The invention further relates to novel processes of preparing novel stem cell lines which are free of animal products, feeder cells, growth factors, leukaemia inhibitory factor, supplementary mineral combinations, amino acid supplements, vitamin supplements, fibroblast growth factor, membrane associated steel factor, soluble steel factor and conditioned media. This invention further relates to the isolation, culture, maintenance, expansion, differentiation, storage, and preservation of such stem cells. | 02-27-2014 |
20140057350 | Compositions Comprising Human Embryonic Stem Cells and Their Derivatives, Methods of Use, and Methods of Preparation - The present invention relates to a pharmaceutical composition comprising of preparations of human embryonic stem (hES) cells and their derivatives and methods for their transplantation into the human body, wherein transplantation results in the clinical reversal of symptoms, cure, stabilization or arrest of degeneration of a wide variety of presently incurable and terminal medical conditions, diseases and disorders. The invention further relates to novel processes of preparing novel stem cell lines which are free of animal products, feeder cells, growth factors, leukaemia inhibitory factor, supplementary mineral combinations, amino acid supplements, vitamin supplements, fibroblast growth factor, membrane associated steel factor, soluble steel factor and conditioned media. This invention further relates to the isolation, culture, maintenance, expansion, differentiation, storage, and preservation of such stem cells. | 02-27-2014 |